Efficacy, Safety and Pharmacokinetics of Tinzaparin During Slow Low Efficient Daily Dialysis in Intensive Care Patients

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 3, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Acute Kidney InjuryRenal Replacement TherapyAnticoagulants

Interventions

DRUG

Tinzaparin continuous infusion

4500 IU continuous infusion of Tinzaparin

DRUG

Tinzaparin bolus

4500 IU bolus of Tinzaparin

Trial Locations (1)

RECRUITING

Tampere University Hospital, Tampere

All Listed Sponsors

lead

Tampere University Hospital

OTHER